Ra Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Boston, MA .
Ra Pharmaceuticals Inc was established in 0, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Douglas Treco, President at the company’s single location by writing to 222 Berkeley St Floor 20, Boston, Massachusetts MA 02116 or by phoning (617) 587-7806. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ra Pharmaceuticals Inc |
| Contact Person: | Douglas Treco, President |
| Address: | 222 Berkeley St Floor 20, Boston, Massachusetts 02116 |
| Phone Number: | (617) 587-7806 |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 4242101 |
| Share This Business: |
Ra Pharmaceuticals Inc was started in 0 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Douglas Treco, President for inquiries that concern Ra Pharmaceuticals Inc by calling the company number (617) 587-7806, as your correspondence is most welcome. Additionally, the physical location of the single location of Ra Pharmaceuticals Inc can be found at the coordinates 42.351028,-71.073034 as well as the street address 222 Berkeley St Floor 20 in Boston, Massachusetts 02116.
For its online presence, you may visit Ra Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.